Search Results

CCT196969 25 mg  | 99.65%

TargetMol

CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, LCK, and the p38 MAPKs.

More Information Supplier Page

PKM2-IN-1 100 mg  | 99.90%

TargetMol

PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.

More Information Supplier Page

PKM2-IN-1 200 mg  | 99.90%

TargetMol

PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.

More Information Supplier Page

PKM2-IN-1 50 mg  | 99.90%

TargetMol

PKM2-IN-1 (compound 3k) displays PKM2 inhibitory activity with the IC50 value of 2.95 μM. The IC50 value for PKM1 is 4-5-fold higher than that for PKM2.

More Information Supplier Page